Patents expiring in 2029

US 7473433

Pulmonary delivery of polyene antifungal agents

Nektar Therapeutics · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7473772

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7473435

Bioactive compositions form Theacea plants and processes for their production and use

INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7473780

Drying process for preparing crystalline solid famciclovir

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7473525

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Europe AG · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476721

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476382

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476402

Methods and compositions for deterring abuse of opioid containing dosage forms

Acurx Pharmaceuticals, Inc. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476535

TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476257

Methods to engineer stratified cartilage tissue

The Regents of the University of California · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476657

Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

Takeda Pharmaceutical Company Limited · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7476682

N-substituted piperidine derivatives as serotonin receptor agents

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479484

Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

Takeda Pharmaceutical Company Limited · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479483

Tumor-targeted drug delivery systems and uses thereof

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479579

Triple transgenic mouse model of Alzheimer's disease

The Regents of the University of California · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479269

Methods for selectively enriching TH1 and TH2 cells

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479274

Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479273

Method of administering and using VEGF inhibitors for the treatment of renal cell cancer

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479275

Method of administering and using VEGF inhibitors for the treatment of colorectal cancer

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479272

Method of administering and using VEGF inhibitors for the treatment of breast cancer

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479551

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479280

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479550

Amyloid β gene vaccines

The Board of Regents of the University of Texas System · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7479562

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482150

Virulent systemic feline calicivirus

The Regents of the University of California · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7481212

Increased dosage metered dose inhaler

Nektar Therapeutics · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482319

Vault and vault-like carrier molecules

The Regents of the University of California · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482024

Compositions comprising an active agent

Nektar Therapeutics · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482331

Diagnosis and treatment of myocardial failure

The Regents of the University of Colorado · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482489

Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482351

4-pyrimidineamine compounds and their uses as anti-proliferative agents

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482470

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7482002

Method of administering and using VEGF inhibitors for the treatment of prostate cancer

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7481995

Aerosol composition

University College Cardiff Consultants Limited · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485651

Compounds with activity on muscarinic receptors

ACADIA Pharmaceuticals Inc. · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485627

Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485415

Sequence analysis of the tetravalent rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485306

Lutzomyia longipalpis polypeptides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485663

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485307

Human cystathionine β-synthase variants and methods of production thereof

The Regents of the University of Colorado · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485311

Methods and compositions for preventing and treating male erectile dysfunction

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485317

Thermo-reversible polymer for intralumenal implant

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485296

PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485440

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485660

Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485451

Storage stable compositions of biological materials

The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485457

Isolated/cloned human NT2 cell lines expressing serotonin and GABA

The United States of America—Department of Veterans Affairs · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7485664

Inhibitors of TACE

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)